-
1مؤتمر
المؤلفون: Lee, Jung-Yun, Makker, Vicky, Manso, Luis, González-Martín, Antonio, Ługowska, Iwona, Lorusso, Domenica, Banerjee, Susana, Liao, John, Lu, Chien-Hsing, Prasongsook, Naiyarat, Melichar, Bohuslav, Chen, Kai, Mcewen, Robert, Michelini, Flavia, Puvvada, Soham, Meric-Bernstam, Funda, Oaknin, Ana
المصدر: Plenary 02: Changing the Landscape of Endometrial Cancer
-
2دورية أكاديمية
المؤلفون: Ahn, Myung-Ju, Mendoza, Marvin Jonne L., Pavlakis, Nick, Kato, Terufumi, Soo, Ross A., Kim, Dong-Wan, Liam, Chong Kin, Hsia, Te-Chun, Lee, Chee Khoon, Reungwetwattana, Thanyanan, Geater, Sarayut, Chan, Oscar Siu Hong, Prasongsook, Naiyarat, Solomon, Benjamin J., Nguyen, Thi Thai Hoa, Kozuki, Toshiyuki, Yang, James Chih-Hsin, Wu, Yi-Long, Mok, Tony Shu Kam, Tan, Daniel Shao-Weng, Yatabe, Yasushi
المساهمون: Kim, Dong-Wan
مصطلحات موضوعية: CELL LUNG-CANCER, EXON 14 MUTATIONS, OSIMERTINIB PLUS SAVOLITINIB, PHASE-II PLATFORM, OPEN-LABEL, INTERNATIONAL-ASSOCIATION, CLINICAL-OUTCOMES, SKIPPING MUTATION, CHINESE PATIENTS, TARGETING MET, Asia-Pacific, Lung cancer, MET amplification in EGFR TKI resistance, MET exon 14 mutation, MET inhibitors
العلاقة: Clinical Lung Cancer, Vol.23 No.8, pp.670-685; https://hdl.handle.net/10371/189407Test; 000905581000014; 2-s2.0-85138556009; 177003